Conscious Wealth Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-146,657
Closed -$3.99M 68
2026
Q1
$3.99M Buy
146,657
+3,279
+2% +$87.3K 2.22% 24
2025
Q4
$3.8M Buy
143,378
+2,264
+2% +$57.1K 2.28% 23
2025
Q3
$3.48M Buy
141,114
+157
+0.1% +$3.88K 2.06% 23
2025
Q2
$3.43M Buy
140,957
+706
+0.5% +$16.5K 2.19% 24
2025
Q1
$3.13M Buy
140,251
+35,807
+34% +$937K 2.17% 28
2024
Q4
$2.75M Buy
104,444
+2,574
+3% +$69.8K 1.86% 29
2024
Q3
$2.94M Buy
101,870
+437
+0.4% +$12.7K 2.02% 27
2024
Q2
$2.99M Sell
101,433
-1,456
-1% -$40.1K 2.15% 19
2024
Q1
$2.64M Buy
102,889
+67,975
+195% +$1.89M 2.01% 27
2023
Q4
$960K Buy
+34,914
New +$1.06M 0.77% 39

Other funds holding PFE

Conscious Wealth Investments's PFE Position: Q2 2026 in Review

Conscious Wealth Investments sold out of Pfizer (PFE) in Q2 2026, closing a stake of 146,657 shares — an estimated $3.99M sold.

Conscious Wealth Investments first reported a position in PFE in Q4 2023 and held it in 10 quarters. The position peaked at $3.99M in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Conscious Wealth Investments reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Conscious Wealth Investments sold 146,657 Pfizer shares in Q2 2026, an estimated $3.99M.
  • Conscious Wealth Investments first reported a position in Pfizer in Q4 2023 and held it in 10 quarters.
  • Conscious Wealth Investments's Pfizer position peaked at $3.99M in Q1 2026.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Conscious Wealth Investments's 13F filing for Q2 2026, filed 11 Aug 2026.